PSORIASIS TREATMENT
Since treatment of nail psoriasis is always disappointing, before treatment is started the
individual problems of every patient should be carefully considered, and in particular the
degree of discomfort that results from the nail lesions. Reassuring the patient is probably
the best approach for isolated nail pitting, oily patches, mild onycholysis and splinter
haemorrhages. However, diffuse onycholysis, subungual hyperkeratosis and severe nail
plate surface abnormalities may require a positive therapeutic approach.
Local therapies of nail psoriasis only rarely induce complete
remission of the disease
When the nail folds are affected, regular application of topical emollients is useful to
reduce scaling and prevent self-induced trauma.
Topical steroids, or combinations of topical steroids with salicylic acid and/or retinoic
acid, are widely prescribed. Their efficacy is poor, even when applied with occlusive
dressing after chemical or mechanical avulsion of the onycholytic nail plate. Long-term
application of topical steroids may result in marked atrophy of the soft tissues of the
digits or even in focal resorption of the distal phalanges.
A nail lacquer containing 8% clobetasol propionate, formulated to optimize
penetration of the drug through the nail plate, has been developed for use in this
condition. This topical treatment, which is effective and well tolerated, produces
improvement in most cases of nail psoriasis, with effects directly related to the duration
of treatment.
Topical calcipotriol is effective when onycholysis and subungual hyperkeratosis are
prominent symptoms. Topical tazarotene 0.1 % gel has also been used with good results
and tolerability in psoriasis. The latter drug is especially effective in reducing
onycholysis (in occluded and non-occluded nails) and pitting (in occluded nails).
Topical psoralens followed by exposure to ultraviolet-A (PUVA) are not very effective
owing to poor penetration of the UVA through the nail plate, especially when the plate is
thickened. However, this treatment may be useful in pustular psoriasis when recurrent
pustular lesions have destroyed the nail plate. Intralesional injections of triamcinolone
acetonide 10 mg/ml, at a dose of 0.2–0.5 ml per nail, have proved effective in some cases
of nail matrix psoriasis. In patients with nail-plate surface abnormalities the steroids
should be injected in the nail matrix, whereas in patients with subungual hyperkeratosis
the site of injection should be the nail bed. Injections should be repeated monthly for 6
months, then every 6 weeks for the next 6 months and finally every 2 months for 6–12
months. A digital block is sometimes useful to make the treatment less painful, but when
several digits are involved, a wrist block may be the appropriate anaesthesia. However,
routine use of this treatment is not recommended because of the pain caused by the
injections, the local side-effects and recurrence of the nail abnormalities after
discontinuation of the therapy. In addition, the efficacy of intralesional steroids in nail
matrix psoriasis is limited, with only 50% success in treating nail pits.
Systemic treatment with methotrexate or cyclosporin can clear the nail changes, but
this can be recommended only when nail psoriasis is associated with widespread disease
or psoriatic arthritis.
Retinoids are of little value in the treatment of nail psoriasis except for hyperkeratotic
nails and pustular psoriasis. Oral administration of etretinate or acitretin can even worsen
the nail changes owing to the development of nail brittleness, pyogenic granuloma-like
lesions and chronic paronychia. Oral photochemotherapy can improve crumbling of the
nail plate and psoriatic involvement of the proximal nail fold, but is less effective in nail
pitting or subungual hyperkeratosis. Superficial radiotherapy can have a beneficial effect
on psoriatic nails but is not recommended because the benefits are short-lived.
Pustular psoriasis of the nail unit usually fails to respond to conventional topical
treatments. Local treatment with topical anti-metabolites (mechlorethamine, 1 %
fluorouracil) is an option, even though results are variable. Systemic steroids, PUVA and
cyclosporin can arrest the development of pustular lesions and avoid permanent scarring
of the nail apparatus. A study of 46 patients with pustular psoriasis of the nails indicates
that systemic retinoids at low dosage (less than 0.5 mg of acitretin per day) are the
treatment of choice in patients with multiple nail involvement, whereas topical
calcipotriol is the best option for pustular psoriasis limited to one or two nails. Topical
calcipotriol is also useful as maintenance therapy in patients who responded to retinoids,
in order to prevent recurrence.

Posted March 5, 2008
Comments(2)